Jonathan Michael Marron, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Treatment Refusal | 4 | 2021 | 420 | 1.900 |
Why?
|
Medical Oncology | 15 | 2022 | 2098 | 1.500 |
Why?
|
Patient Participation | 3 | 2022 | 1447 | 1.290 |
Why?
|
Dissent and Disputes | 3 | 2023 | 145 | 1.220 |
Why?
|
Ethics Consultation | 2 | 2022 | 42 | 1.150 |
Why?
|
Decision Making | 9 | 2022 | 3802 | 1.110 |
Why?
|
Hodgkin Disease | 2 | 2021 | 1412 | 0.970 |
Why?
|
Informed Consent By Minors | 1 | 2021 | 6 | 0.870 |
Why?
|
Neoplasms | 12 | 2021 | 20172 | 0.840 |
Why?
|
Parental Consent | 1 | 2021 | 57 | 0.830 |
Why?
|
Healthcare Disparities | 3 | 2021 | 2996 | 0.810 |
Why?
|
Metaphor | 1 | 2020 | 36 | 0.800 |
Why?
|
Brain Death | 1 | 2023 | 305 | 0.760 |
Why?
|
Complementary Therapies | 2 | 2021 | 517 | 0.750 |
Why?
|
Personal Autonomy | 1 | 2021 | 301 | 0.720 |
Why?
|
Informed Consent | 4 | 2022 | 959 | 0.710 |
Why?
|
Ethics | 1 | 2017 | 94 | 0.650 |
Why?
|
Genetic Testing | 3 | 2022 | 3303 | 0.610 |
Why?
|
Morals | 2 | 2020 | 263 | 0.600 |
Why?
|
Physician-Patient Relations | 4 | 2019 | 3316 | 0.600 |
Why?
|
Medical Futility | 1 | 2017 | 129 | 0.600 |
Why?
|
Bioethics | 1 | 2017 | 107 | 0.600 |
Why?
|
Liver Failure | 1 | 2017 | 233 | 0.570 |
Why?
|
Resuscitation Orders | 1 | 2017 | 272 | 0.550 |
Why?
|
Parents | 8 | 2023 | 3154 | 0.520 |
Why?
|
Social Justice | 1 | 2018 | 420 | 0.510 |
Why?
|
Pandemics | 4 | 2021 | 7089 | 0.500 |
Why?
|
Neuroblastoma | 1 | 2021 | 1180 | 0.490 |
Why?
|
Truth Disclosure | 1 | 2017 | 439 | 0.490 |
Why?
|
Pediatrics | 5 | 2021 | 3554 | 0.490 |
Why?
|
Withholding Treatment | 1 | 2017 | 580 | 0.480 |
Why?
|
Social Class | 1 | 2021 | 1925 | 0.440 |
Why?
|
Death | 1 | 2016 | 573 | 0.440 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3153 | 0.430 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3275 | 0.430 |
Why?
|
Communication | 4 | 2022 | 3455 | 0.420 |
Why?
|
Health Status Disparities | 1 | 2021 | 1711 | 0.370 |
Why?
|
Osteosarcoma | 1 | 2015 | 891 | 0.370 |
Why?
|
Hematology | 2 | 2022 | 195 | 0.370 |
Why?
|
Terminal Care | 2 | 2018 | 1632 | 0.360 |
Why?
|
Leukemia, Myeloid, Acute | 2 | 2020 | 3281 | 0.340 |
Why?
|
Secondary Prevention | 1 | 2015 | 1505 | 0.340 |
Why?
|
Health Care Rationing | 2 | 2021 | 455 | 0.320 |
Why?
|
Socioeconomic Factors | 1 | 2021 | 7644 | 0.320 |
Why?
|
Child | 16 | 2023 | 73636 | 0.300 |
Why?
|
Hematologic Neoplasms | 1 | 2017 | 1687 | 0.290 |
Why?
|
Bone Neoplasms | 2 | 2016 | 2579 | 0.290 |
Why?
|
Therapeutic Human Experimentation | 1 | 2005 | 42 | 0.280 |
Why?
|
Humans | 44 | 2023 | 708843 | 0.280 |
Why?
|
Therapies, Investigational | 1 | 2005 | 105 | 0.260 |
Why?
|
Interprofessional Relations | 1 | 2010 | 1016 | 0.260 |
Why?
|
Cholecystectomy, Laparoscopic | 1 | 2005 | 227 | 0.250 |
Why?
|
Drug Industry | 1 | 2010 | 894 | 0.240 |
Why?
|
Stress, Psychological | 1 | 2018 | 4176 | 0.230 |
Why?
|
Paternalism | 1 | 2022 | 46 | 0.230 |
Why?
|
Attitude of Health Personnel | 2 | 2016 | 3885 | 0.200 |
Why?
|
Ethical Theory | 1 | 2020 | 35 | 0.200 |
Why?
|
Connecticut | 1 | 2021 | 363 | 0.200 |
Why?
|
Colectomy | 1 | 2005 | 651 | 0.190 |
Why?
|
Hospitals, Pediatric | 2 | 2019 | 1776 | 0.180 |
Why?
|
Herbal Medicine | 1 | 2019 | 40 | 0.180 |
Why?
|
Parental Notification | 1 | 2017 | 12 | 0.170 |
Why?
|
Mass Media | 1 | 2021 | 315 | 0.170 |
Why?
|
Adolescent | 8 | 2021 | 84718 | 0.170 |
Why?
|
Ethics, Clinical | 1 | 2018 | 97 | 0.170 |
Why?
|
Cultural Diversity | 1 | 2021 | 347 | 0.170 |
Why?
|
State Government | 1 | 2021 | 368 | 0.170 |
Why?
|
Prognosis | 2 | 2019 | 28919 | 0.170 |
Why?
|
Standard of Care | 1 | 2021 | 497 | 0.160 |
Why?
|
Infant | 5 | 2021 | 34261 | 0.160 |
Why?
|
Ethics, Research | 1 | 2018 | 181 | 0.160 |
Why?
|
Professional-Family Relations | 1 | 2021 | 473 | 0.160 |
Why?
|
Radiation Oncology | 1 | 2022 | 507 | 0.150 |
Why?
|
Uncertainty | 1 | 2020 | 642 | 0.150 |
Why?
|
Esthesioneuroblastoma, Olfactory | 1 | 2015 | 52 | 0.140 |
Why?
|
Remission Induction | 1 | 2021 | 2399 | 0.140 |
Why?
|
Professional-Patient Relations | 1 | 2021 | 725 | 0.140 |
Why?
|
Choice Behavior | 1 | 2021 | 793 | 0.140 |
Why?
|
History, 21st Century | 1 | 2021 | 1569 | 0.130 |
Why?
|
Health Communication | 1 | 2017 | 213 | 0.130 |
Why?
|
Specialties, Surgical | 1 | 2019 | 387 | 0.130 |
Why?
|
Gender Identity | 1 | 2019 | 554 | 0.130 |
Why?
|
Trust | 1 | 2017 | 478 | 0.120 |
Why?
|
Nose Neoplasms | 1 | 2015 | 244 | 0.120 |
Why?
|
Nasal Cavity | 1 | 2015 | 307 | 0.120 |
Why?
|
Ethics, Medical | 1 | 2019 | 803 | 0.120 |
Why?
|
Child, Preschool | 4 | 2021 | 41081 | 0.110 |
Why?
|
Fatal Outcome | 1 | 2017 | 1887 | 0.110 |
Why?
|
Burnout, Professional | 1 | 2020 | 628 | 0.110 |
Why?
|
Cerebellar Neoplasms | 1 | 2016 | 601 | 0.110 |
Why?
|
Minority Groups | 1 | 2018 | 1077 | 0.100 |
Why?
|
Databases, Genetic | 1 | 2018 | 1807 | 0.100 |
Why?
|
Artificial Intelligence | 1 | 2022 | 1661 | 0.100 |
Why?
|
Medulloblastoma | 1 | 2016 | 715 | 0.100 |
Why?
|
Biopsy | 2 | 2019 | 6766 | 0.090 |
Why?
|
Insurance Coverage | 1 | 2021 | 1847 | 0.090 |
Why?
|
Poverty | 1 | 2021 | 2557 | 0.090 |
Why?
|
Adult | 6 | 2021 | 211041 | 0.090 |
Why?
|
Public Health | 1 | 2021 | 2363 | 0.090 |
Why?
|
Psychometrics | 1 | 2017 | 2966 | 0.090 |
Why?
|
Marketing | 1 | 2010 | 240 | 0.090 |
Why?
|
Male | 10 | 2021 | 349524 | 0.080 |
Why?
|
United States | 4 | 2021 | 67165 | 0.080 |
Why?
|
Critical Care | 1 | 2020 | 2473 | 0.080 |
Why?
|
Cohort Studies | 2 | 2021 | 39292 | 0.080 |
Why?
|
Clinical Trials as Topic | 2 | 2020 | 8024 | 0.080 |
Why?
|
Practice Guidelines as Topic | 2 | 2021 | 7487 | 0.070 |
Why?
|
Conflict of Interest | 1 | 2010 | 564 | 0.070 |
Why?
|
Young Adult | 4 | 2021 | 55940 | 0.070 |
Why?
|
Biomedical Research | 1 | 2020 | 3266 | 0.070 |
Why?
|
Analgesics, Opioid | 1 | 2020 | 3308 | 0.060 |
Why?
|
Needs Assessment | 1 | 2010 | 1147 | 0.060 |
Why?
|
Genomics | 2 | 2016 | 5300 | 0.060 |
Why?
|
Anxiety | 1 | 2017 | 3887 | 0.060 |
Why?
|
Ethicists | 1 | 2022 | 33 | 0.060 |
Why?
|
Paranasal Sinuses | 1 | 2005 | 270 | 0.060 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2019 | 5135 | 0.050 |
Why?
|
Ethics Committees | 1 | 2020 | 52 | 0.050 |
Why?
|
Patient Rights | 1 | 2021 | 124 | 0.050 |
Why?
|
National Cancer Institute (U.S.) | 1 | 2021 | 249 | 0.050 |
Why?
|
Cross-Sectional Studies | 2 | 2021 | 23020 | 0.050 |
Why?
|
Hospital Bed Capacity | 1 | 2021 | 199 | 0.050 |
Why?
|
Middle Aged | 3 | 2020 | 213752 | 0.050 |
Why?
|
Female | 6 | 2021 | 375205 | 0.040 |
Why?
|
Depression | 1 | 2017 | 7202 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2021 | 13714 | 0.040 |
Why?
|
Cancer Care Facilities | 1 | 2021 | 414 | 0.040 |
Why?
|
Infant, Newborn | 1 | 2017 | 24433 | 0.040 |
Why?
|
Penetrance | 1 | 2019 | 359 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2016 | 8877 | 0.040 |
Why?
|
Health Priorities | 1 | 2021 | 388 | 0.040 |
Why?
|
Educational Status | 1 | 2022 | 2278 | 0.030 |
Why?
|
Models, Theoretical | 1 | 2005 | 3558 | 0.030 |
Why?
|
Self Efficacy | 1 | 2016 | 629 | 0.030 |
Why?
|
Aged | 3 | 2019 | 161488 | 0.020 |
Why?
|
Societies, Medical | 1 | 2020 | 3776 | 0.020 |
Why?
|
Palliative Care | 1 | 2021 | 3261 | 0.020 |
Why?
|
Patient Education as Topic | 1 | 2016 | 2340 | 0.020 |
Why?
|
Research Design | 1 | 2020 | 5833 | 0.020 |
Why?
|
Treatment Outcome | 2 | 2015 | 61932 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2016 | 2878 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2015 | 8896 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2020 | 4810 | 0.010 |
Why?
|
Age Factors | 1 | 2019 | 18712 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2016 | 9556 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2019 | 17218 | 0.010 |
Why?
|
Risk Assessment | 1 | 2016 | 23284 | 0.010 |
Why?
|
Mutation | 1 | 2016 | 29262 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2015 | 71483 | 0.010 |
Why?
|